If you’re in Savannah, Georgia this week for the American Society for Microbiology’s Clinical Virology Symposium, NeuMoDx™ teammate Jason has a message for you!
Stop by booth #547 now through Wednesday, May 8 at #ASMCVS – we can’t wait to show you the future of molecular diagnostics.
We are excited to announce that QIAGEN has acquired all shares of NeuMoDx Molecular, Inc. The addition of NeuMoDx’s medium- and high-throughput molecular systems further expands QIAGEN’s portfolio of molecular diagnostics instruments, bolstering our leadership in automated molecular testing. We are proud to welcome NeuMoDx to our family of PCR solutions that make improvements in life possible.
To learn more, click here.
